跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
PALYNZIQ
Authorized
STANDARD
PALYNZIQ
Biomarin International Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b5b57303cfc892e4
Company
Biomarin International Limited
Type
Standard
Approval Details
Approval Id
b5b57303cfc892e4
Drug Approval Canada Name
PALYNZIQ
Product Name
PALYNZIQ
Status
Marketed
Status Date
2022-08-26
Original Market Date
2022-08-26
Din
02526255
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
44:00.00
Atc Original
A16AB19 PEGVALIASE
Atc Name
a 16 ab 19
Aig Number
0163521001
Company Name
Biomarin International Limited
Company Address
Shanbally, Ringaskiddy, Cork, Ireland, P43R298
Company Detail Path
/organization/biomarin-international-limited
Company Information
Pharmaceutical Company Name
Biomarin International Limited
Country Name
Australia
Active Ingredients
PEGVALIASE
10 MG / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b5b57303cfc892e4
Type
Standard
Back to Health Canada Approvals
PALYNZIQ - Health Canada Drug Approval Details